Trial Condition(s):

Atrial Fibrillation

Xarelto for prevention of stroke in patients with atrial fibrillation (XANTUS)

Bayer Identifier:

15914

ClinicalTrials.gov Identifier:

NCT01606995

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This is an international observational study in patients with non-valvular atrial fibrillation who are prescribed rivaroxaban under routine treatment conditions to prevent stroke or non-central nervous system systemic embolism.

Inclusion Criteria
:
  - Female and male patients ≥ 18 years of age with a diagnosis of non-valvular atrial fibrillation who start treatment with rivaroxaban to prevent stroke or non-CNS (Central Nervous System) systemic embolism, and who consent to participate in the study
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
6784
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Xarelto (Rivaroxaban, BAY59-7939)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Germany

Status
Completed
 
Locations

Investigative Site

Many Locations, United Kingdom

Status
Completed
 
Locations

Investigative Site

Many Locations, France

Status
Completed
 
Locations

Investigative Site

Many Locations, Poland

Status
Completed
 
Locations

Investigative Site

Many Locations, Belgium

Status
Completed
 
Locations

Investigative Site

Many Locations, Netherlands

Status
Completed
 
Locations

Investigative Site

Many Locations, Sweden

Status
Completed
 
Locations

Investigative Site

Many Locations, Denmark

Status
Completed
 
Locations

Investigative Site

Many Locations, Norway

Status
Completed
 
Locations

Investigative Site

Many Locations, Czech Republic

Status
Completed
 
Locations

Investigative Site

Many Locations, Israel

Status
Completed
 
Locations

Investigative Site

Many Locations, Portugal

Status
Completed
 
Locations

Investigative Site

Many Locations, Austria

Status
Completed
 
Locations

Investigative Site

Many Locations, Hungary

Status
Completed
 
Locations

Investigative Site

Many Locations, Russia

Status
Completed
 
Locations

Investigative Site

Many Locations, Slovakia

Status
Completed
 
Locations

Investigative Site

Many Locations, Ukraine

Status
Completed
 
Locations

Investigative Site

Many Locations, Slovenia

Status
Completed
 
Locations

Investigative Site

Many Locations, Ireland

Status
Completed
 
Locations

Investigative Site

Many Locations, Moldova

Status
Completed
 
Locations

Investigative Site

Many Locations, Canada

Status
Completed
 

Trial Design